Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

COVID-19 and its vaccines can cause various skin issues, with urticaria being the most common.

COVID-19 can cause temporary hair loss.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

Chronic stress increased after lockdown, especially in young adults and females.

Shirodhara may help improve mental well-being, but more research is needed.

Expanding telemedicine in Japan reduced healthcare costs without harming health outcomes.

Hematopoietic stem cell transplantation does not significantly affect COVID-19 severity in children with immune disorders.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Post-COVID conditions increase health care needs for six months after infection.

The document says hair loss can happen after recovering from COVID-19 and it can cause psychological discomfort.

COVID-19 can cause hair and nail disorders after infection.

COVID-19 can cause significant hair loss.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

COVID-19 can increase the risk of hair loss, especially in people over 40.

COVID-19 can cause temporary hair loss in some people.

Higher testosterone and lower Vitamin D levels are linked to hair loss in female COVID-19 patients.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

A guide and infographics were created to help healthcare professionals manage post-COVID conditions effectively.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Incorporating epidemic history into medical education is crucial to better address post-epidemic health challenges.

Long COVID symptoms are common and the new method will help test if remdesivir reduces them.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.